ED-BRIDGE | EMERGENCY BUPRENORPHINE TREATMENT

REFERENCES

Work set forth by ED-BRIDGE is based on experience as well as references that include, but is not limited to, the below publications

 
 

Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, and Mattick RP. 


Bell J, Trinh L, Butler B, Randall D, and Rubin G. 


Berg ML, Idrees U, Ding R, Nesbit SA, Liang HK, and McCarthy ML. 

(2007) Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department. Drug Alcohol Depend. 2007;86(2-3):239-44. doi:10.1016/j.drugalcdep.2006.06.014.


Bhatraju E, Grossman E , Tofighi B, McNeely J, DiRocco D, Flannery M, Garment A , Goldfeld K , Gourevitch M and Lee J.

(2017) Public sector low threshold office-based buprenorphine treatment: outcomes at year 7. Addict Sci Clin Pract. 2017; 12:7 DOI 10.1186/s13722-017-0072-2


Cunningham C, Roose R, Starrels J, Giovanniello A, Sohler N.

(2013) Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes. J Addict Med. 2013 Jul-Aug; 7(4): 287–293. doi:  10.1097/ADM.0b013e31829727b2


Clark RE, Samnaliev M, Baxter JD, and Leung GY. 


Cunningham CO, Roose RJ, Starrels JL, Giovanniello A, Sohler NL.

(2013) Prior Buprenorphine Experience Is Associated With Office-Based Buprenorphine Treatment Outcomes. J Addict Med 2013 Jul-Aug;7(4):287-93. doi: 10.1097/ADM.0b013e31829727b2.


D'Onofrio G, O'Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, and Fiellin DA. 


D’Onofrio, G, Chawarski M, O'Connor P, Pantalon M, Busch S, Owens P, Hawk K, Bernstein S, Fiellin D.


Fugelstad A, Stenbacka M, Leifman A, Nylander M, and Thiblin I. 

(2007) Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction. 2007;102(3):406-12. doi:10.1111/j.1360-0443.2006.01714.x.


Gowing L, Farrell M, Bornemann R, and Ali R. 

(2008) Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004145. doi: 10.1002/14651858.CD004145.pub3.


Larochelle MR, Bernson D, Land T, Stopka T, Wang N, Xuan Z, Bagley S, Liebschutz J, Walley A.


Lee J, Grossman E, DiRocco D, Gourevitch M.

(2009) Home buprenorphine/naloxone induction in primary care. J Gen Intern Med. 2009 Feb;24(2):226-32. doi: 10.1007/s11606-008-0866-8. 


Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, and Robertson JR. 


Marsden, J, Stillwell, G, Jones, H, Cooper, A, Eastwood, B, Farrell, M, Lowden, T, Maddalena, N, Metcalfe, C, Shaw, J, and Hickman, M.


Mattick RP, Breen C, Kimber J, and Davoli M. 

(2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207. doi:10.1002/14651858.CD002207.pub4.


Pierce M, Bird SM, Hickman M, Marsden J, Dunn G, Jones A, and Millar T. 


Raffa, R.B., Haidery, M., Huang, H.M., Kalladeen, K., Lockstein, D.E., Ono, H., Shops, M.J., Sowunmi, O.A., Tran, J.K.


Sordo L, Barrio G, Bravo M, Indave B, Degenhardt L, Wiessig L, Ferri M, Pastor-Barriuso R.


Sigmon S, Ochalek T, Meyer A, Hruska B, Heil S, Badger G, Rose, G, Brooklyn J.

(2016) Interim Buprenorphine vs. Waiting List for Opioid Dependence. N Engl J Med.375;25 nejm.org December 22, 2016.


Sporer KA. 

(2003) Strategies for preventing heroin overdose. BMJ. 2003;326(7386):442-4. doi:10.1136/bmj.326.7386.442.


Ward J, Hall W, and Mattick RP.

(1999) Role of maintenance treatment in opioid dependence. Lancet. 1999;353(9148):221-6. doi:10.1016/S0140-6736(98)05356-2.